Agrochemical

Syngenta Provides Study List for the Renewal of Mesotrione Approval

Updated on

News Brief

Syngenta Crop Protection AG has submitted a comprehensive list of intended studies to the relevant EU authorities to support its application for the renewal of the active substance mesotrione. This submission is a key step in the regulatory process governed by Regulation (EU) 2020/1740.

This move by Syngenta initiates the next phase of the renewal process for mesotrione, a widely used herbicide. The European Food Safety Authority (EFSA) recently concluded a public consultation (PC‑1663) on this list of studies, the deadline for which was 12 November 2025. The consultation allowed interested parties to provide input on the proposed research.

What is Mesotrione

Mesotrione is a systemic herbicide belonging to the triketone chemical class, widely used for selective weed control in maize. It acts by inhibiting the enzyme 4‑hydroxyphenylpyruvate dioxygenase (HPPD), leading to chlorosis and death of susceptible plants. As with all EU‑approved active substances, its renewal involves a complete re‑evaluation of human health, environmental, and ecotoxicological data to confirm that it continues to meet the safety criteria under Regulation (EC) No 1107/2009.

Next Steps

Upon closure of the consultation, EFSA will review all contributions and integrate relevant input into its pre‑submission advice. Syngenta is required to provide a dossier to support the renewal of mesotrione by May 31, 2029.

Newsletter Subscription

Sign up to receive event invitations, expert insights, timely news alerts, and other updates.

SUBSCRIBE

Contact Us

REACH24H USA

+1 703 596 8055

REACH24H EU

+353 1 8899 951

REACH24H UK

+44 782 7193124

REACH24H China

+86 571 87103805

REACH24H Korea

+82 2 62451610

REACH24H Japan

+03 5005 0662

REACH24H Singapore

Events

Market Insights & Registration Regulations of European Pesticides and Strategic Recommendations CRAC China 2025: Global Pesticide Registration and Practical Innovation
Full Image